Saturday, 1st October 11:00 SESSION II
/ Chairs: F. Aucella; L. Gottin

CARDIAC SURGERY

P66

Evaluation of a system for cytokines adsorption in a population of critically ill patients: a single center experienceRama J, Ceola Graziadei M, Corubolo L, Russo A, De Vigili A, Vignola A, Falcioni E, Donadello K, Polati E, Gottin LVerona

P67

Combined treatment with IgM enriched immunoglobulin and CytoSorb® in Infective Endocarditis: Case SeriesPaternoster G, Covino A, Vitiello M, Vignale R, Gallicchio F, Tucciariello MT, Pittella GPotenza

P68

Apixaban Blood Levels reduced by the Use of CytoSorb® added to Cardio-Pulmonary BypassNardi M, Damato I, Caso A, Distaso F, Aucella F, Grandone E, Greco FSan Giovanni Rotondo

P70

Use of Cytosorb® in a patient with Septic and Cardiogenic Shock by Fulminant Autoimmune MyocarditisLisi P, Teutonico A, Pezzuto M, Del Monte V, Montinaro VAcquaviva delle Fonti

P71

The use of CytoSorb® in patients with Cardiogenic Shock treated with VA-ECMO SupportBerardi M, Ramoni E, Ceresa R, Zulueta JL, Mazzanti GP, Perrucci F, Sutera Sardo S, Lamarra MBologna

P72

Early use of Cytosorb during CPB in patients undergoing surgery for bacterial endocarditisTenga N, Marsicano C, Mastroianni A, Ruotolo F, Di Gennaro TLCaserta

P75

The role of Pancreatic Stone Protein as an Early Biomarker of Sepsis in Cardiac Surgery and Heart TransplantationRaimondo P, De Palma F, Fiorentino M, Rubino G, Lenoci S, Stripoli A, Armenise A, Villani MA, Colantuono G, Fiore G, Gesualdo L, Grasso SBari

P76

Pancreatic Stone Protein (PSP) predicts Perioperative Sepsis in Critically Ill patients undergoing Cardiac SurgeryFiorentino M, Raimondo P, De Palma F, Carparelli S, Stasi A, Franzin R, Schirinzi A, Di Serio F, Bottio T, Milano AD, Grasso S, Gesualdo LBari